X Factor Tulisa: I stole bags, took drugs and lost my virginity aged 14 Daily Mail Her reputation for telling it like it is attracted Simon Cowell's eye and landed her a starring role on the X Factor panel. But the music mogul may now be questioning his judgment following Tulisa Contostavlos's latest interview, … Simon Cowell will judge both UK and US X Factor finalsMetro
X Factor 2011: Simon Cowell will judge contestants via satellite linkUnreality TV RIHANNA IS READY TO SPARK ANOTHER HOT DEBATEDaily Star
Lady Gaga: Drugs "Made Me Feel I Had a Friend” NBC Chicago And when Lady Gaga made her first appearance on Howard Stern's show, neither held much back. She copped to past use of Ecstasy and cocaine, saying she was drawn to the latter because she was lonely, EW.com reported. “There was something about the drug … Gaga: Drugs made me feel like I had a friendmsnbc.com
Lady Gaga to Howard Stern: 'I Don't Give a F–k About Money'Billboard Lady Gaga's Drug Confession to Howard Stern: Cocaine Is "The Devil"E! Online (blog) The Daily Blabber from iVillage -Hollywood.com -The Stir all 151 news articles »
Gaga: Drugs made me feel like I had a friend msnbc.com Lady Gaga spoke bluntly about the drug use in her past, but encouraged young fans to stay away from substance abuse. By Gina Serpe There seems to be nothing Lady Gaga won't share with her Little Monsters. And Howard Stern, well, you'd be hard-pressed … Lady Gaga Dishes On Sex, Drugs, Born This Way On Howard SternMTV.com
Lady Gaga Talks Sex and Drugs With Howard SternHollywood.com Lady Gaga's Drug Confession to Howard Stern: Cocaine Is "The Devil"E! Online (blog) TheCelebrityCafe.com -Entertainment Weekly -Gather.com all 112 news articles »
Lycera Announces Research Collaboration With Merck To Discover, Develop And Commercialize Drugs For Autoimmune Diseases
Lycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has entered into an exclusive research collaboration with Merck to discover, develop and commercialize small molecules that target T-helper 17 (Th17) cells, key mediators of inflammation. The collaboration will focus on …
Blockbuster Drugs In The Biotech Sector Analyzed By Institutional Investor Award Winning Analyst With RBC Capital …
67 WALL STREET, New York – November 22, 2010 – The Wall Street Transcript has just published its Biotechnology & Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 81 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by …
Oligomerix, Inc. Awarded Phase II NIH Grant To Discover Novel Drugs For Alzheimer’s Disease
Oligomerix, Inc. announced the receipt of a two-year Small Business Innovation Research (SBIR) Phase II grant for $1.6M from the National Institute on Aging, National Institutes of Health (NIH), for a program to discover small molecules and antibodies targeting tau protein oligomers in the development of disease modifying therapeutics for Alzheimer’s disease. Compound libraries will be screened …
Body Clock Drugs Could Ease Psychiatric Disorders And Jet Lag
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Medical Research Council (MRC) have successfully used a drug to reset and restart the natural 24 hour body clock of mice in the lab. The ability to do this in a mammal opens up the possibility of dealing with a range of human difficulties including some psychiatric disorders, jet lag and the health …
Scripps spinoff conducts research that may produce therapeutic drugs
JUPITER — As Florida taxpayers bet big on biotech, start-up firm cuRNA offers a microcosm of the risky and potentially lucrative business of turning laboratory research into blockbuster drugs.
www.encognitive.com Angell disputes the industry’s reputation as an “engine of innovation,” arguing that the top US drug makers spend 2.5 times as much on marketing and administration as they do on research. At least a third of the drugs marketed by industry leaders were discovered by universities or small biotech companies, writes Angell, but they’re sold to the public at inflated prices. She cites Taxol, the cancer drug discovered by the National Institutes of Health, but sold by Bristol-Myers Squibb for $20000 a year, reportedly 20 times the manufacturing cost. The company agreed to pay the NIH only 0.5 percent in royalties for the drug. The majority of the new products the industry puts out, says Angell, are “me-too” drugs, which are almost identical to current treatments but “no better than drugs already on the market to treat the same condition.” Around 75 percent of new drugs approved by the FDA are me-too drugs. They can be less effective than current drugs, but as long as they’re more effective than a placebo, they can get the regulatory green light. http
